Chris Bauer
Overview
Explore the profile of Chris Bauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Blazquez-Navarro A, Roch T, Wehler P, Stervbo U, Bauer C, Wolk K, et al.
J Nephrol
. 2022 Dec;
36(4):1071-1073.
PMID: 36459372
No abstract available.
12.
Klafki H, Vogelgsang J, Manuilova E, Bauer C, Jethwa A, Esselmann H, et al.
Alzheimers Res Ther
. 2022 Sep;
14(1):127.
PMID: 36071505
Background: Measurements of the amyloid-β (Aβ) 42/40 ratio in blood plasma may support the early diagnosis of Alzheimer's disease and aid in the selection of suitable participants in clinical trials....
13.
Wanner C, Schuchhardt J, Bauer C, Lindemann S, Brinker M, Kong S, et al.
J Nephrol
. 2022 May;
36(1):45-54.
PMID: 35567698
Background: The observational, real-world evidence FLIEDER study aimed to describe patient clinical characteristics and investigate clinical outcomes in non-diabetic patients with chronic kidney disease (CKD) using data collected from routine...
14.
Blazquez-Navarro A, Bauer C, Wittenbrink N, Wolk K, Sabat R, Dang-Heine C, et al.
Curr Res Transl Med
. 2022 Feb;
70(3):103334.
PMID: 35193070
Purpose Of The Study: Long-term graft survival rates after renal transplantation are still poor. We aimed to build an early predictor of an established long-term outcomes marker, the estimated glomerular...
15.
Benson G, Bauer C, Hausner L, Couturier S, Lewczuk P, Peters O, et al.
J Neural Transm (Vienna)
. 2022 Jan;
129(5-6):477-486.
PMID: 35061102
ApoE4, the strongest genetic risk factor for Alzheimer's disease (AD), has been shown to be associated with both beta-amyloid (Aβ) and tau pathology, with the strongest evidence for effects on...
16.
Prasse P, Iversen P, Lienhard M, Thedinga K, Bauer C, Herwig R, et al.
NAR Genom Bioinform
. 2022 Jan;
4(1):lqab128.
PMID: 35047818
Computational drug sensitivity models have the potential to improve therapeutic outcomes by identifying targeted drug components that are likely to achieve the highest efficacy for a cancer cell line at...
17.
Blazquez-Navarro A, Dang-Heine C, Wehler P, Roch T, Bauer C, Neumann S, et al.
Transpl Int
. 2021 Aug;
34(9):1680-1688.
PMID: 34448272
Epstein-Barr virus (EBV) reactivation is a very common and potentially lethal complication of renal transplantation. However, its risk factors and effects on transplant outcome are not well known. Here, we...
18.
Bauer C, Herwig R, Lienhard M, Prasse P, Scheffer T, Schuchhardt J
J Transl Med
. 2021 Jun;
19(1):274.
PMID: 34174885
Background: There is a huge body of scientific literature describing the relation between tumor types and anti-cancer drugs. The vast amount of scientific literature makes it impossible for researchers and...
19.
Blazquez-Navarro A, Dang-Heine C, Bauer C, Wittenbrink N, Wolk K, Sabat R, et al.
Front Pharmacol
. 2021 Feb;
11:534681.
PMID: 33519427
Post-transplantation cytomegalovirus (CMV) syndrome can be prevented using the antiviral drug (val)ganciclovir. (Val)ganciclovir is typically administered following a prophylactic or a pre-emptive strategy. The prophylactic strategy entails early universal administration,...
20.
Menne F, Schipke C, Klostermann A, Fuentes-Casan M, Freiesleben S, Bauer C, et al.
J Alzheimers Dis
. 2020 Oct;
78(2):819-826.
PMID: 33074230
Background: Depressive symptoms often co-occur with Alzheimer's disease (AD) and can impact neuropsychological test results. In early stages of AD, disentangling cognitive impairments due to depression from those due to...